Literature DB >> 10837382

Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

C Giusti1, R Schiaffini, C Brufani, A Pantaleo, E M Vingolo, P Gargiulo.   

Abstract

AIMS: To investigate whether diabetic retinopathy (DR), already associated with microvascular alterations, ischaemia, and endothelial dysfunction, was also characterised by abnormal modulation of coagulation pathways.
METHODS: Plasma samples, collected from 67 type 1 diabetics comparable for age, duration of disease (DD), and metabolic control (MC), were processed for prothrombin degradation products (F1+2) and factor VII coagulant activity (FVII:c). 50 normal subjects served as a control group. The ETDRS-Airlie House Classification of DR was used.
RESULTS: A significant correlation between FVII:c and F1+2 plasma concentrations was observed (p <0.05). FVII:c (p <0.005) and F1+2 (p <0.0001) levels were higher in diabetics than in controls, especially in patients with proliferative DR (FVII:c p <0.0001; F1+2 p<0.005). However, cases without retinal lesions and healthy subjects did not differ significantly (FVII:c and F1+2 p >0.05).
CONCLUSIONS: These findings pointed out the presence of a hypercoagulable state associated with endothelial dysfunction in patients with insulin dependent diabetes mellitus (IDDM), demonstrated both by increased FVII:c and F1+2 plasma levels. Moreover, the observation of different DR related degrees of procoagulant activity, despite comparable DD and MC, strengthens the hypothesis of multiple risk factors in the pathogenesis of DR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837382      PMCID: PMC1723519          DOI: 10.1136/bjo.84.6.591

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  41 in total

1.  Increased von Willebrand-antihaemophilic factor a in diabetic retinopathy.

Authors:  M Pandolfi; L O Almér; L Holmberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

2.  Treatment of nonproliferative diabetic retinopathy with Defibrotide in noninsulin-dependent diabetes mellitus: a pilot study.

Authors:  E M Vingolo; G De Mattia; C Giusti; R Forte; O Laurenti; M R Pannarale
Journal:  Acta Ophthalmol Scand       Date:  1999-06

3.  Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage.

Authors:  O Laurenti; E M Vingolo; G B Desideri; C Ferri; C Bellini; M Cassone-Faldetta; A Santucci; G De Mattia
Journal:  Exp Clin Endocrinol Diabetes       Date:  1997       Impact factor: 2.949

4.  Retinopathy in young-onset diabetic patients.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Diabetes Care       Date:  1985 Jul-Aug       Impact factor: 19.112

5.  The 14-year incidence of visual loss in a diabetic population.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

6.  Multiple factors in the prediction of risk of proliferative diabetic retinopathy.

Authors:  L I Rand; A S Krolewski; L M Aiello; J H Warram; R S Baker; T Maki
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

7.  Is cigarette smoking associated with diabetic retinopathy?

Authors:  R Klein; B E Klein; M D Davis
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

8.  Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics.

Authors:  T L Dornan; A Ting; C K McPherson; C O Peckar; J I Mann; R C Turner; P J Morris
Journal:  Diabetes       Date:  1982-03       Impact factor: 9.461

9.  Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.

Authors:  J M Teitel; K A Bauer; H K Lau; R D Rosenberg
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

10.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20
View more
  1 in total

1.  Evaluation of serum fibrinogen, plasminogen, α2-anti-plasmin, and plasminogen activator inhibitor levels (PAI) and their correlation with presence of retinopathy in patients with type 1 DM.

Authors:  Sefika Burcak Polat; Nagihan Ugurlu; Fatma Yulek; Huseyin Simavli; Reyhan Ersoy; Bekir Cakir; Ozcan Erel
Journal:  J Diabetes Res       Date:  2014-04-10       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.